Cover image not available

Omalizumab for the treatment of severe persistent allergic asthma in children aged 6 to 11 years : This guidance was developed using the single technology appraisal process

National Institute for Health and Clinical Excellence

Publication Data

Title Omalizumab for the treatment of severe persistent allergic asthma in children aged 6 to 11 years : This guidance was developed using the single technology appraisal process
Author National Institute for Health and Clinical Excellence
Publisher National Institute for Health and Clinical Excellence
Publication date 2010
Publication location London
Language English

Descriptive Notes

Issue date: October 2010.

Topics

Asthma in children :: Chemotherapy :: England
Asthma in children :: Chemotherapy :: Wales
Monoclonal antibodies

Catalogue Data

OBNB ID GBB586365
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 618.92238

ISBD

P1053 1 online resource (38 pages).
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Omalizumab for the treatment of severe persistent allergic asthma in children aged 6 to 11 years : This guidance was developed using the single technology appraisal process by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2010. Publication and catalogue information, links to buy online and reader comments.